Hideki Makishima

17PUBLICATIONS
102CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Regenerative medicine (incl. stem cells)Haematological tumoursEconometric and statistical methodsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 27, 2025
Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351.

Hideki Makishima, Taisuke Mikasa, Kento Isogaya

|Feb 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT.

Carmelo Gurnari, Marie Robin, Lionel Adès

|Sep 24, 2024
Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevance.

Qingbo S Wang, Takanori Hasegawa, Ho Namkoong

|Dec 01, 2022
DDX41-associated susceptibility to myeloid neoplasms.

Hideki Makishima, Teresa V Bowman, Lucy A Godley

|Nov 02, 2022
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.

Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya

|Jul 15, 2022
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.

June Takeda, Kenichi Yoshida, Masahiro M Nakagawa

Pageof 3

Frequent Collaborators

4 joint publications

Hiroko Tanaka

4 joint publications

Ryunosuke Saiki

4 joint publications

Satoru Miyano

3 joint publications

Cassandra M Kerr